Pramana Achieves Industry-Leading Milestone with Digital Pathology 2.0 Technology

[ad_1]

Over 6.5 Million Glass Slides Digitized within the Final 12 Months and 15 Billion Pictures Validated with Close to-Excellent Accuracy Utilizing Pramana’s Modern In-Line High quality Assurance Algorithms

CAMBRIDGE, Mass., March 22, 2024–(BUSINESS WIRE)–Pramana, Inc., will showcase its suite of transformative options enabling Digital Pathology 2.0 on the USCAP annual conference in Baltimore, MD, March 25-28, 2024, at sales space #549. Pramana will spotlight its in depth expertise and modern applied sciences, together with the creation of the world’s largest DICOM repository of entire slide photographs for anatomic pathology, serving a few of its flagship clients.

With a mission to revolutionize the panorama of pathology labs, Pramana is on the forefront of the “lab of the long run” motion, leveraging automation and AI-driven autonomous operations to sort out the urgent challenges of labor shortages and rising prices confronted by labs throughout the US. Pramana’s technological developments have empowered digitizing initiatives at an unprecedented price with industry-leading efficiencies. Pramana’s cutting-edge entire slide imaging know-how achieves first-pass success in scanning practically any slide appropriate for viewing beneath an optical microscope. By harnessing these developments, labs can optimize their every day operations and improve their diagnostic capabilities.

“In 2023, Pramana established a big presence in entire slide imaging in the US – quick ahead to at the moment, we’re digitizing over 1 million glass slides month-to-month, catering to each archival and scientific purposes,” stated Prasanth Perugupalli, Pramana’s Chief Product Officer. “Our strides in advancing digital pathology, in collaboration with Picture Administration System companions, have led to the creation of the most important DICOM dataset for digital pathology, paving the best way for a future the place proprietary picture codecs are not needed and marking a brand new period in digital pathology.”

Pramana’s patented volumetric imaging know-how has revolutionized entire slide imaging and has been tailored to handle essentially the most difficult areas within the area. Historically troublesome for different imaging programs resulting from technological limitations, Pramana has efficiently prolonged its volumetric imaging know-how from tissue imaging to microbiology, cytology, and parasitology purposes. For all the above purposes, Pramana has prolonged its absolutely autonomous in-line high quality assurance, leading to a dramatic discount within the whole time and price of digital operations earlier than a pathologist views the picture on a pc monitor.

“Groundbreaking enhancements in software program structure have enabled us to reveal that the function descriptor algorithms will be programmed to run in actual time on the scanner throughout the acquisition of the high-power photographs on the glass slide. This transformational breakthrough permits for additional enrichment of digital photographs with actionable outcomes with out time delays, on the lowest prices the {industry} has ever incurred. The economics of digital pathology are actually prepared for a re-visit,” Perugupalli stated.

Two poster presentations at USCAP spotlight Pramana’s developments in in-line computation of morphological options, which help in actionable outcomes for pathologists.

For extra info on Pramana’s digital pathology choices, go to sales space #549 at USCAP or schedule a meeting.

About Pramana, Inc.

Pramana, Inc. is a well being know-how firm enabling seamless digital adoption by pathology labs and medical facilities. The turnkey digital pathology transformation is supported by cutting-edge programs and a scalable software program platform. For extra info, go to www.pramana.ai or LinkedIn.

View supply model on businesswire.com: https://www.businesswire.com/news/home/20240322179056/en/

Contacts

Media Contact
Andrea Sampson, Sampson Public Relations Group
[email protected]

[ad_2]

Source link